Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2023-07-04 | 2024-02-07 | 197195 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-03-14 | 2018-02-21 | 2374 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-03-14 | 2018-03-08 | 2380 |
TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2017-09-21 | 2018-03-07 | 22945 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-08-14 | 2018-01-03 | 19304 |
TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2018-03-13 | 2018-10-11 | 42622 |
RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-07-02 | 2019-07-16 | 88167 |
TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2017-08-14 | 2017-09-19 | 19308 |
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-05-10 | 2017-09-19 | 9785 |
RATIO-LACTULOSE | 667MG/ML | BOTTLE | Resolved | 2017-03-14 | 2017-12-15 | 2400 |
RATIO-LACTULOSE | 667MG | SOLUTION | Actual shortage | 2024-05-03 | 2024-05-03 | 226933 |
TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3118 |
TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2017-03-15 | 2017-12-15 | 2986 |
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3121 |
RATIO-METFORMIN | 850MG | TABLET | Resolved | 2017-04-03 | 2017-10-10 | 5168 |
RATIO-METFORMIN | 850MG | TABLET | Resolved | 2019-09-05 | 2020-07-10 | 93162 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2017-11-16 | 2018-01-04 | 29441 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-13 | 2020-02-13 | 1739 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-17 | 2017-04-25 | 3148 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92678 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |